Long-term evolution of anti-HCV-positive renal transplant recipients.
Aroldi
A
A
Div Nefrologia e Dialisi, Ospedale Maggiore, IRCCS, Milano, Italia.
Lampertico
P
P
Elli
A
A
Lunghi
G
G
Tarantino
A
A
Montagnino
G
G
Colombo
M
M
Ponticelli
C
C
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001803:Blood Transfusion; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006526:Hepatitis C / Q000150:complications / Q000401:mortality / Q000503:physiopathology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D015996:Survival Rate; D013997:Time Factors
D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine